Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by ArteFill Users

Articles with lock require a subscription to GLG News | Request a free trial
Sunil DhawanSeptember 28, 2007
Relieva results in recent clinical trial for eczema
Analysis of: Relieva Exceeds Expectations In Recent Clinical Trial For Eczema (Atopic Dermatitis) | www.medicalnewstoday.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
The recent results for a trial of Relieva in atopic dermatitis or eczema, a cream containing a homeopathic compound, were positive by a report from the company. The study sample was small, and the trial was open label. Generally these trials have a larger number of patients, and are blinded. Also it...
September 24, 2007
This treatment is unsafe and regulation is going to make it obsolete for a time
Analysis of: Feel Pudgy? There’s a Shot for That | www.nytimes.com
Author: GLG Expert Contributor
This treatment is run illegally, in violation of FDA laws Additionally, it is outlawed in Europe, Canada and Brazil, among other places Lastly, it isn't all that effective, from what I hear, and very painful.  In summary, better options will become available.
Sunil DhawanSeptember 10, 2007
FDA issues warning to Melanocorp
Analysis of: FDA Issues Warning Letter To Melanocorp, Inc. For Illegal Sale Of Melanotan II -Agency Warns Consumers About Using And Purchasing Unapproved Product | www.medicalnewstoday.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
 The FDA warning to Melanocorp regarding their product Melanotan was justified. These warnings are far too few and infrequent, and numerous companies make claims without studies or substantiation. The agency is overwhelmed with NDA's, and has difficulty handling the work that currently exists....
Gregory BufordSeptember 6, 2007
First step in the right direction
Analysis of: Investigational New Drug Application For 'Fat Melting' Injections Cleared By The FDA | www.medicalnewstoday.com
Author: Gregory Buford, Plastic Surgeon and Medical Director , BEAUTY by BUFORD
1.  Fat removal/body contouring procedures are becoming increasingly popular in North America and show potential for increasing growth.        2.  The trend towards less invasive means for body contouring has shown dramatic growth, as well.    3. ...
August 28, 2007
This coud ne a Panora's Box
Analysis of: New Medicare Regulations Adopted To Reduce Certain Hospital Infections And Medical Errors | www.medicalnewstoday.com
Author: Michael Bain, Plastic and Reconstructive Physician, Michael A Bain, MD
If a patient gets a bedsore, who pays for it? Most importantly, what does this mean to KCI and the other wound companies? Where will it end?
July 30, 2007
They have improved, but they are not the holy grail
Analysis of: Recurrence of Spider Angiomas After Laser Treatment | dermatology.jwatch.org
Author: Michael Bain, Plastic and Reconstructive Physician, Michael A Bain, MD
Lasers are better than they were 10 years ago.  Especially for vascular lesions; however, they are not all purpose machines that can do everything, as evidenced by new ones every year.
July 12, 2007
I would love it
Analysis of: Norwegian hacker says he can bypass AT&T on iPhone | today.reuters.com
Author: Michael Bain, Plastic and Reconstructive Physician, Michael A Bain, MD
It would be great to get an unlocked i-phone...
Sunil DhawanJuly 12, 2007
Vaniqa's effect on laser hair removal
Analysis of: Laser Hair Removal Enhanced With Eflornithine Cream | www.medscape.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
I do not believe that Vaniqa will have a negative effect on Laser hair removal as its efficacy is only temporary. In fact we use it as an adjunct for patients with resistant areas. Its use may actually enhance the use of Laser devices as they offer permanence. The products use may be increasing as more...
Sunil DhawanJune 18, 2007
Dermlex Launch
Analysis of: Advitech to finally launch Dermylex in US | www.nutraingredients-usa.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
Advitech's launch of Dermylex will not have much of an impact on the psoriasis market. This is due to the fact that the product has minimal studies to back it up, and the company will rely on testimonials. This is not an effective way of marketing to physicians, and is difficult with patients....
Sunil DhawanJune 4, 2007
Melafind Phase three implications
Analysis of: Digital Diagnosis: New Tool for Detecting Skin Cancer | www.ehponline.org
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
If Melafinds phase three study results are positive then physicians will in general be receptive. The only issues are: 1. Ease of use/time to scan 2. Ability for non physician personnel to be trained to use the technology. 3. cost 4. Insurance reimbursement The technology may have more use at larger...

Previous Page : 1 2 3 4 5 6 7 8 9 Next31 to 40 of 82

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T17:45:17.637